Stocks · Korea 009290 KOSPI

Kwangdong Pharmaceutical

6,900원 +1.47% Market cap 3,436억 2026-10-07 close

📈 Chart & live quote

Data as of 2026-10-07 · Linked from 8 pages

An overview for this page is not available in English yet. The figures below are updated daily.

Key figures 2026-10-07 basis

PER13.24x

PBR0.52x

EPS521 KRW

BPS13,201 KRW

ROE3.11%

Dividend yield1.45%

DPS100 KRW

Payout ratio19.19%

Returns and 52-week range

1W+8.83%

1M+8.83%

3M+14.62%

6M-21.23%

1Y+16.75%

YTD+17.95%

52W high12,800원

52W low5,150원

From 52W high-46.09%

Financial results (consolidated)

Period	Revenue	Operating income	Net income	OP margin
2022	1.4조	382억	267억	2.7%
2023	1.5조	421억	394억	2.8%
2024	1.6조	301억	418억	1.8%
2025	1.7조	310억	213억	1.9%
Quarterly
2024 4Q	3,908억	67억	128억	1.7%
2025 1Q	3,776억	33억	41억	0.9%
2025 2Q	4,253억	45억	24억	1.1%
2025 3Q	4,445억	109억	111억	2.5%
2025 4Q	4,121억	123억	38억	3.0%
2026 1Q	4,109억	75억	49억	1.8%

Company

CEO최성원, 박상영(각자대표)

Founded1963-10-16

Fiscal year end12

Websitewww.ekdp.com

Address: 경기도 과천시 과천대로7다길 52 광동 과천 타워

Peers in the same sector

Company	Market cap	P/E	P/B	1M
동아에스티	3,444억	—	0.53	-4.07%
한스바이오메드	3,223억	—	9.07	+16.92%
삼양바이오팜	3,710억	165.78	1.58	-30.03%
유바이오로직스	3,120억	7.53	1.78	-1.04%
메디포스트	3,917억	—	1.57	+14.96%
휴온스글로벌	3,032억	10.12	0.53	+1.27%

Recent filings

2026-08-14반기보고서 (2026.06)
2026-05-15분기보고서 (2026.03)
2026-03-26주요사항보고서(자기주식처분결정) Major
2026-03-18사업보고서 (2025.12)
2025-12-23주요사항보고서(자기주식처분결정) Major
2025-11-14분기보고서 (2025.09)
2025-10-28[기재정정]주요사항보고서(자기주식처분결정) Major
2025-10-28[기재정정]주요사항보고서(교환사채권발행결정) Major
2025-10-20[정정명령부과]주요사항보고서(자기주식처분결정) Major
2025-10-20[정정명령부과]주요사항보고서(교환사채권발행결정) Major

Source: DART (Financial Supervisory Service electronic disclosure)

Sources and notes

This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.